// App-Quantinova.ai

: Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease

Researchers

Presenter

  • Declan Doherty

Principal Investigators

  • Lydia Roets

  • Rebecca Delaney

  • Anna Krasnodembskaya

  • Marcus A. Mall

  • Clifford C. Taggart

  • Sinead Weldon

Medical Centers

  • Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, United Kingdom

  • Wellcome-Wolfson Institute of Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom

  • Department of Pediatric Pulmonology and Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany and Berlin Institute of Health (BIH), Berlin, Germany, Berlin, Germany

Locations

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Mesenchymal stem cells

  • Translocator protein

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A